Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding.
Displaying 3981 - 4000 of 6103
Barnekow, Merilou; d/b/a Womens Menopause Health Center., In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
072-3143
C-4208
ADT Security Services, Inc., United States of America (for the FTC)
Type of Action
Federal
Last Updated
FTC Matter/File Number
042-3091
Green Willow Tree, The, LLC, and Robert Burns, In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
072-3144
Black, Shelley, an individual trading and d/b/a Progesterone Advocates Network, In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
072-3146
Health Science International, Inc., and David Martin, In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
072-3145
Elation Therapy, Inc. and Robert Rutledge., In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
072 3142
Ameriquest Mortgage Company., United States of America (for the FTC)
Type of Action
Federal
Last Updated
FTC Matter/File Number
042-3082
Craftmatic Industries, Inc., et al., United States of America (for the FTC)
Type of Action
Federal
Last Updated
FTC Matter/File Number
042 3094
Direct Security Services, Inc., et al., United States of America (for the FTC)
Type of Action
Federal
Last Updated
FTC Matter/File Number
042 3091
Guardian Communications, Inc., et al. U.S. (for the FTC)
Type of Action
Federal
Last Updated
FTC Matter/File Number
052-3166
Mylan Laboratories Inc. and E. Merck oHG., In the Matter of
The Commission ordered divestitures to resolve competitive concerns in the U.S. market for five generic drugs stemming from Mylan Laboratories’ proposed acquisition of the generic arm of Merck Pharmaceuticals, a transaction valued at approximately $6.6 billion. Under a September 2007 consent order with the Commission, Mylan and Merck must divest all assets relating to flecainide acetate tablets, acebutolol hydrochloride capsules, guanfacine hydrochloride tablets, nicardipine hydrochloride capsules, and sotalol hydrochloride. The generic drugs at issue are used for the treatment of many conditions, including hypertension and heart arrhythmia. The order requires the divestiture of all assets related to the relevant products to Amneal Pharmaceuticals, a generic drug manufacturer.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0710164
Universal Advertising, Inc., a Utah corporation; and Paul E. Porter, individually and as an officer of Universal Advertising, Inc.
Type of Action
Federal
Last Updated
FTC Matter/File Number
062 3228
Asset Protection Group, Inc. and William S. Reed
Type of Action
Federal
Last Updated
FTC Matter/File Number
072-3159
Centurion Financial Benefits, et al.
Type of Action
Federal
Last Updated
FTC Matter/File Number
052 3072
Displaying 3981 - 4000 of 6103